证券代码：002496 证券简称：*ST辉丰 公告编号：2025-036 江苏辉丰生物农业股份有限公司 关于公司董事、监事、高级管理人员辞职及补选公司非独立董事的公告 本公司及董事会、监事会全体成员保证信息披露的内容真实、准确、完整，没 有虚假记载、误导性陈述或重大遗漏。 江苏辉丰生物农业股份有限公司（以下简称"公司"）董事会于近日收到公司董事、副 总经理、财务负责人周京先生和董事杨进华女士的书面辞职报告。周京先生因个人原因辞去 公司第九届董事、战略委员会委员及副总经理、财务负责人职务；杨进华女士因根据《中国 中化企业领导人员公司外兼职管理细则》的要求辞去公司第九届董事会董事、审计委员会委 员职务。周京先生、杨进华女士辞职后，将不再担任公司其他职务。 公司监事会于近日收到公司监事施伟锋先生的的书面辞职报告。施伟锋先生因公司工作 调整原因辞去公司第九届监事会监事职务。 公司对周京先生、杨进华女士、施伟锋先生在任职期间勤勉尽责，为公司发展作出的贡 献表示衷心感谢！ 公司于 2025 年 10 月 27 日召开第九届董事会第十二次会议，审议通过了《关于补选公 司非独立董事的议案》。因董事周京先生、杨进华女士辞去公司 ...

Financial Performance - The company's operating revenue for the third quarter reached ¥62,102,694.79, representing a year-on-year increase of 42.95%[5] - The net profit attributable to shareholders was -¥14,692,782.66, a decline of 56.08% compared to the same period last year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥18,339,335.40, a decrease of 53.13% year-on-year[5] - The basic and diluted earnings per share were both -¥0.0097, a decrease of 56.31% compared to the previous year[5] - The net profit for the current period was a loss of ¥6,936,185.15, compared to a profit of ¥58,515.69 in the previous period, indicating a substantial decline[22] - The company reported an operating profit of ¥4,060,739.45, recovering from an operating loss of ¥196,321.84 in the previous period[22] - The basic and diluted earnings per share for the current period were both -0.0021, compared to 0.0009 in the previous period, indicating a negative shift[22] Assets and Liabilities - The total assets at the end of the reporting period amounted to ¥2,267,725,919.65, showing a slight decrease of 0.29% from the end of the previous year[5] - The total assets decreased slightly to ¥2,267,725,919.65 from ¥2,274,291,204.20, reflecting a reduction of about 0.3%[20] - Total liabilities decreased to ¥987,734,306.41 from ¥1,002,085,571.44, showing a decline of approximately 1.4%[20] - The total equity attributable to shareholders of the parent company was ¥1,324,547,003.96, down from ¥1,328,376,939.84, a decrease of about 0.3%[20] Cash Flow - The cash flow from operating activities for the year-to-date was -¥18,116,830.21, reflecting a decline of 33.98%[5] - The company’s cash flow from operating activities showed improvement, with a net cash inflow reported[21] - Net cash flow from operating activities was -¥18,116,830.21, an improvement compared to -¥27,440,856.49 in the previous period[23] - Operating cash inflow for the current period reached ¥1,547,423,920.10, an increase from ¥1,369,415,115.54 in the previous period, representing a growth of approximately 13.06%[23] - Cash inflow from investment activities totaled ¥49,248,243.32, slightly down from ¥52,555,354.74 in the previous period[23] - Net cash flow from investment activities increased to ¥38,879,999.99 from ¥35,165,567.54 year-over-year[23] - Cash inflow from financing activities was ¥222,857,000.00, up from ¥213,000,000.00 in the previous period, marking an increase of approximately 8.67%[24] - Net cash flow from financing activities improved to -¥10,635,056.96 from -¥30,736,275.85 in the previous period[24] Shareholder Information - The total number of common shareholders at the end of the reporting period is 31,813[10] - The largest shareholder, Zhang Hangen, holds 28.75% of the shares, totaling 433,423,393 shares[10] - The actual controller, Zhang Hangen, holds 43,342.34 million shares, accounting for 28.75% of the total share capital[16] - The company has not reported any changes in the participation of major shareholders in margin trading and securities lending[11] Other Income and Costs - The company reported a significant increase in investment income, reaching ¥49,158,063.61, a year-on-year increase of 4589.40%[7] - The total operating costs rose to ¥203,450,492.18, an increase of 70.34% year-on-year, driven by higher trade business revenue[7] - The company recorded a substantial increase in other income, totaling ¥1,264,872.02, a decrease of 57.45% compared to the previous year due to reduced government subsidies[7] - Total operating costs increased to ¥294,962,881.08 from ¥226,222,601.90, marking a rise of about 30.4%[21] Inventory and Receivables - Accounts receivable decreased significantly from ¥81,238,491.24 to ¥16,803,709.24, a reduction of about 79.3%[18] - Inventory increased to ¥74,545,626.82 from ¥57,481,221.30, reflecting a rise of approximately 29.8%[18] Equity Transactions - The company completed the transfer of 51% equity in a subsidiary to ADM on May 31, 2021[12] - The company has not disclosed any significant litigation matters in the recent report[13]

证券代码：002496 证券简称：*ST 辉丰 公告编号：2025-037 江苏辉丰生物农业股份有限公司 第九届董事会第十二次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、 误导性陈述或重大遗漏。 一、董事会会议召开情况 江苏辉丰生物农业股份有限公司（以下简称"公司"）第九届董事会于2025年10月16日 以通讯方式向公司董事发出关于召开公司第九届董事会第十二次会议的通知。本次会议于 2025年10月27日在公司会议室以现场结合通讯方式召开，全体董事9人参加会议，会议由公 司董事长仲汉根先生主持。 1、审议通过《2025年三季度报告》 公司前三季度实现营业收入219,125,723.79元，同比增长42.7%；前三季度归属于上市公 司股东的净利润为-3,227,461.80，同比减少347.45%，归属于上市公司股东的扣除非经常性 损益的净利润-27,491,404.12，同比增长70.62%。 详见同日刊登于《中国证券报》、《证券时报》和巨潮资讯网上的《2025年三季度报告》， 公告编号：2025-038。 表决结果：9票同意，0票反对，0票弃权。 2、审议通过《关于 ...

Core Insights - The fungicide industry is experiencing rapid growth in China, driven by increasing public health awareness and environmental policies, with the market size projected to grow from 23.67 billion yuan in 2019 to 40.5 billion yuan by 2024, representing a compound annual growth rate (CAGR) of 11.34% [2][10] - The demand for environmentally friendly and biological fungicides is expected to rise significantly, particularly in the agricultural sector, which is the primary consumer market for fungicides [2][10] Industry Overview - Fungicides, also known as biocides, are chemical agents that effectively control or kill microorganisms such as bacteria, fungi, and algae [3] - The classification of fungicides can be based on application fields (industrial and agricultural), raw materials (inorganic, organic sulfur, organic phosphorus, etc.), usage methods (protective and therapeutic), and conduction characteristics (systemic and non-systemic) [3][8] Industry Policies - The Chinese fungicide industry is at a critical juncture influenced by policy changes and market transformations, with recent regulations aimed at promoting green and efficient fungicide production [5][7] - Key policies include the restriction of high-toxicity and high-residue pesticide production, as outlined in the "Industrial Structure Adjustment Guidance Catalog (2024 Edition)" [5][7] Industry Chain - The fungicide industry chain consists of upstream raw materials and production equipment, midstream research and manufacturing, and downstream applications in agriculture, forestry protection, urban greening, industrial corrosion prevention, and medical disinfection [8][10] Current Market Status - The global fungicide market is steadily expanding, with a projected market size of 19.704 billion USD in 2024, reflecting a year-on-year growth of 3.15% [10] - The growth is driven by the need for agricultural yield enhancement, public health protection, and food safety assurance, with expectations for the market to reach 22.942 billion USD by 2028 [10]

Market Overview - The agricultural chemical sector experienced a decline of 1.46% on October 17, with Xinong Co. leading the drop [1] - The Shanghai Composite Index closed at 3839.76, down 1.95%, while the Shenzhen Component Index closed at 12688.94, down 3.04% [1] Stock Performance - Notable gainers in the agricultural chemical sector included: - Chengxing Co. (600078) with a closing price of 10.26, up 9.97% [1] - Lanfeng Biochemical (002513) at 8.44, up 3.81% [1] - Xianda Co. (603086) at 10.14, up 2.94% [1] - Major decliners included: - Xinong Co. (002942) at 23.81, down 10.02% [2] - Baiao Chemical (603360) at 25.41, down 3.60% [2] - Fengshan Group (603810) at 16.74, down 3.13% [2] Capital Flow - The agricultural chemical sector saw a net outflow of 62.58 million yuan from institutional investors and 93.96 million yuan from retail investors, while retail investors had a net inflow of 157 million yuan [2][3] - Key stocks with significant capital flow included: - Chengxing Co. with a net inflow of 107 million yuan from institutional investors [3] - Lanfeng Biochemical with a net inflow of 84.93 million yuan from institutional investors [3] - Xinong Co. with a net outflow of 56.9 million yuan from institutional investors [3]

Group 1 - The average stock price of A-shares is 13.49 yuan, with 24 stocks priced below 2 yuan, the lowest being *ST Gao Hong at 0.51 yuan [1] - Among the low-priced stocks, 12 are ST stocks, accounting for 50% of the total [1] - The Shanghai Composite Index closed at 3831.66 points as of September 18 [1] Group 2 - Among the low-priced stocks, 11 increased in price today, with the highest gainers being Yongtai Energy (up 10.32%), Liao Port Co. (up 2.75%), and *ST Su Wu (up 2.15%) [1] - Conversely, 11 stocks decreased in price, with the largest declines seen in Rongsheng Development (down 8.54%), *ST Gao Hong (down 5.56%), and Zhitian Tui (down 5.36%) [1] - The stock price performance of low-priced stocks shows a mixed trend, indicating volatility in this segment [1]

Group 1 - The average stock price of A-shares is 13.65 yuan, with 24 stocks priced below 2 yuan, the lowest being *ST Gao Hong at 0.54 yuan [1] - Among the low-priced stocks, 12 are ST stocks, accounting for 50% of the total [1] - The Shanghai Composite Index closed at 3876.34 points as of September 17 [1] Group 2 - Among the low-priced stocks, three increased in price today, with *ST Yuan Cheng leading at a rise of 4.97% [1] - The majority of low-priced stocks, 17 in total, experienced declines, with Rongsheng Development falling by 6.13% [2][1] - The trading volume and turnover rates vary significantly among low-priced stocks, with *ST Gao Hong having a turnover rate of 0.24% [1]

Summary of Key Points Core Viewpoint - The average stock price of A-shares is 13.39 yuan, with 35 stocks priced below 2 yuan, the lowest being *ST Gao Hong at 1.08 yuan [1][2] Group 1: Market Performance - As of August 28, the Shanghai Composite Index closed at 3843.60 points, with a notable presence of low-priced stocks in the market [1] - Among the low-priced stocks, 7 out of 35 increased in price today, with Liao Port Co., He Bang Bio, and Mei Bang Apparel leading with increases of 1.86%, 1.04%, and 1.02% respectively [1] - Conversely, 20 stocks declined, with *ST Gao Hong, *ST Hui Feng, and *ST Su Wu experiencing the largest drops of 5.26%, 1.81%, and 1.71% respectively [1] Group 2: Low-Priced Stocks Overview - The list of low-priced stocks includes 13 ST stocks, accounting for 37.14% of those priced below 2 yuan [1] - The lowest priced stocks are as follows: - *ST Gao Hong: 1.08 yuan, -5.26% daily change, 0.30% turnover rate, 2.11 P/B ratio [1] - *ST Su Wu: 1.15 yuan, -1.71% daily change, 14.02% turnover rate, 0.47 P/B ratio [1] - *ST Jin Ke: 1.34 yuan, no change, 1.97% turnover rate [1] - Other notable low-priced stocks include: - Rongsheng Development: 1.44 yuan, -0.69% daily change [1] - Chongqing Steel: 1.46 yuan, +0.69% daily change [1] - Yung Tai Energy: 1.47 yuan, -0.68% daily change [1]

Group 1 - The core viewpoint of the article highlights that *ST Huifeng (002496) has experienced revenue growth but significant profit decline in its 2025 mid-year report, indicating a challenging financial situation [1] - The company's total operating revenue reached 157 million yuan, a year-on-year increase of 42.6%, while the net profit attributable to shareholders was 11.47 million yuan, a year-on-year decrease of 67.02% [1] - The gross profit margin was reported at 10.01%, down 65.83% year-on-year, and the net profit margin was 5.58%, down 82.21% year-on-year, reflecting deteriorating profitability [1] Group 2 - The company reported a significant increase in sales expenses, management expenses, and financial expenses totaling 57.27 million yuan, which accounted for 36.47% of revenue, a decrease of 42.54% year-on-year [1] - The earnings per share (EPS) decreased to 0.01 yuan, down 67.1% year-on-year, indicating a decline in shareholder returns [1] - The company's historical financial performance has been poor, with a median return on invested capital (ROIC) of -8.51% over the past decade, and a particularly low ROIC of -23.34% in 2023 [3]

Group 1 - The core point of the article is that *ST Huifeng (002496.SZ) released its semi-annual report for 2025, indicating the current status of institutional ownership [1] - As of August 26, 2025, there is one institutional investor holding shares in *ST Huifeng, with a total holding of 30.5953 million shares, representing 2.03% of the total share capital [1] - The institutional investor includes Jiangsu Huifeng Biological Agriculture Co., Ltd. - Phase I Employee Stock Ownership Plan, maintaining the same holding percentage [1]